Author at Microdose

Caine Barlow

Caine Barlow is a Mycologist and Fungi Educator based in Melbourne, Australia. He gives regular talks on mycology, fungi conservation, and teaches gourmet mushroom cultivation. He is a member of the Australian organisations Entheogenesis Australis, MYCOmmunity Applied Mycology, and The Australian Psychedelic Society. He edited the Australian Entheogenic Compendium (Volume One) and was lead editor of the Entheogenesis Australis 2017 Journal.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Culture

29 Apr 2022

Entheogens: A Look at Modern Culture and History

Although used for millennia by indigenous cultures around the world, there was a modern psychedelic renaissance with a history of its own...

By Caine Barlow

Culture

7 Apr 2022

Entheogenic Culture and History (part 2)

There is the deeper narrative, a much older narrative; one of traditional use, of societies that used Entheogens as a fundamental part of society and culture....

By Caine Barlow

Culture

3 Mar 2022

A Look at Entheogenic Culture and History

For most of us, the consciousness we experience in our day-to-day lives, what we perceive to be “normal,” is directed towards just that, the day-to-day....

By Caine Barlow

Science

8 Feb 2022

Entheogens and Plant Medicine: An Introduction

There are many vision-inducing plants found in nature, with many cultures having sought the divine through changes in consciousness, breathing techniques, singing & dancing, and a variety of plant medicines....

By Caine Barlow

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

Latest News

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts

Caine Barlow is a Mycologist and Fungi Educator based in Melbourne, Australia. He gives regular talks on mycology, fungi conservation, and teaches gourmet mushroom cultivation. He is a member of the Australian organisations Entheogenesis Australis, MYCOmmunity Applied Mycology, and The Australian Psychedelic Society. He edited the Australian Entheogenic Compendium (Volume One) and was lead editor of the Entheogenesis Australis 2017 Journal.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

WordPress Ads